Literature DB >> 31549188

Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis.

Sang Hun Lee1, Kyung Ok Ko1, Jae Woo Lim1, Jung Min Yoon1, Young Hwa Song1, Jong Wook Lee2, Eun Jung Cheon3.   

Abstract

DNI is the immature granulocyte fraction provided by a blood cell analyzer, which is determined by subtracting the fraction of mature polymorphonuclear leukocytes from the sum of myeloperoxidase-reactive cells. We aimed to evaluate the role of Delta-neutrophil index (DNI) in cardiac prognosis prediction in children with Kawasaki disease (KD). Medical records of 193 patients were retrospectively reviewed. The values of DNI, white blood cells, erythrocyte sedimentation rate, the percent of polymorphonuclear leucocytes, C-reactive protein, aspartate transaminase, alanine aminotransferase, total bilirubin data of children with KD were analyzed. Also, sex and age of children were compared. The value of DNI was higher in children with cardiac complications [median 0.8 (0-0.26) vs 5.3 (3.55-8.95); P < 0.001]. The ROC curves showed that DNI was a better predictor of cardiac complications than other parameters. The best cutoff value for DNI to predict cardiac complications was 5.55% with sensitivity of 80% and specificity of 82% (AUC 0.883, 95% confidence interval [CI] 0.807-0.959, P < 0.05). DNI could serve as a facile and useful marker to predict cardiac complications in children with KD, as it is included in a routine complete blood count.

Entities:  

Keywords:  Coronary aneurysms; Delta-neutrophil index; Kawasaki disease; Prognosis

Mesh:

Substances:

Year:  2019        PMID: 31549188     DOI: 10.1007/s00296-019-04448-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Authors:  Tohru Kobayashi; Yoshinari Inoue; Kazuo Takeuchi; Yasunori Okada; Kazushi Tamura; Takeshi Tomomasa; Tomio Kobayashi; Akihiro Morikawa
Journal:  Circulation       Date:  2006-05-30       Impact factor: 29.690

2.  Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.

Authors:  Kee-Soo Ha; Jeehoo Lee; Gi Young Jang; JungHwa Lee; Kwang Chul Lee; Chang Sung Son; Joo Won Lee
Journal:  Am J Cardiol       Date:  2015-04-18       Impact factor: 2.778

Review 3.  The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.

Authors:  Jane C Burns; Alessandra Franco
Journal:  Expert Rev Clin Immunol       Date:  2015       Impact factor: 4.473

Review 4.  Clinical utility of the band count.

Authors:  P Joanne Cornbleet
Journal:  Clin Lab Med       Date:  2002-03       Impact factor: 1.935

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

Review 6.  The genetics of Kawasaki disease.

Authors:  Yoshihiro Onouchi
Journal:  Int J Rheum Dis       Date:  2017-11-19       Impact factor: 2.454

7.  Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis.

Authors:  Chung Hyun Nahm; Jong Weon Choi; Jongwook Lee
Journal:  Ann Clin Lab Sci       Date:  2008       Impact factor: 1.256

8.  Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.

Authors:  DooIl Song; Yunku Yeo; KeeSoo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2009-01-22       Impact factor: 3.183

9.  The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Authors:  Ji Whan Han
Journal:  Korean Circ J       Date:  2017-03-08       Impact factor: 3.243

10.  Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease.

Authors:  Soo Jin Kim
Journal:  Korean Circ J       Date:  2018-04       Impact factor: 3.243

View more
  2 in total

1.  Delta neutrophil index and C-reactive protein: a potential diagnostic marker of multisystem inflammatory syndrome in children (MIS-C) with COVID-19.

Authors:  Cuneyt Karagol; Ali Kansu Tehci; Ali Gungor; Zahide Ekici Tekin; Elif Çelikel; Fatma Aydın; Tuba Kurt; Müge Sezer; Nilüfer Tekgöz; Serkan Coşkun; Melike Mehveş Kaplan; Gulsum Iclal Bayhan; Husniye Nese Yaralı; Namuk Yasar Ozbek; Banu Çelikel Acar
Journal:  Eur J Pediatr       Date:  2021-10-14       Impact factor: 3.860

Review 2.  Kawasaki syndrome: role of superantigens revisited.

Authors:  Donald Y M Leung; Patrick M Schlievert
Journal:  FEBS J       Date:  2020-08-24       Impact factor: 5.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.